- ICH GCP
- US Clinical Trials Registry
- Search trials
Clinical Trials on COVID in Poland
Total 252 results
-
Stanford UniversityMedical University of South Carolina; National Heart, Lung, and Blood Institute... and other collaboratorsCompleted
-
Gilead SciencesTerminatedCOVID-19Spain, United States, United Kingdom, Portugal, Brazil, South Africa
-
AstraZenecaCompletedCOVID-19United States, Spain, United Kingdom, Brazil, Germany, Ukraine, Japan, Italy, Poland, Russian Federation, Mexico, Czechia, Argentina, Hungary, Peru
-
Gilead SciencesCompletedCOVID-19United States, Spain, United Kingdom, Hong Kong, Taiwan, Italy, France, Korea, Republic of, Switzerland, Germany, Netherlands, Singapore, Sweden, China, Japan
-
National Institute of Allergy and Infectious Diseases...CompletedCOVID-19United States, Korea, Republic of
-
University of ManitobaUniversity Health Network, TorontoCompletedCOVID-19 | PneumoniaUnited States, Brazil, Canada, Mexico
-
Ansun Biopharma, Inc.RecruitingCOVID-19 | Lower Respiratory Tract Infection | Immunocompromised | ParainfluenzaUnited States, Australia, China, Denmark, France, Hong Kong, Korea, Republic of, Taiwan
-
National Institute of Allergy and Infectious Diseases...CompletedCOVID-19United States, Japan, Mexico, Singapore, Korea, Republic of
-
Gilead SciencesCompletedCOVID-19United States, Spain, United Kingdom, Hong Kong, Taiwan, Italy, France, Korea, Republic of, Switzerland, Germany, Netherlands, Singapore, Sweden, China, Japan
-
National Institute of Allergy and Infectious Diseases...Bristol-Myers Squibb; Eli Lilly and Company; AstraZeneca; AIDS Clinical Trials... and other collaboratorsCompletedCovid19 | CoronavirusUnited States, Argentina, Brazil, Guatemala, Mexico, Philippines, Puerto Rico, South Africa, Canada
-
Regeneron PharmaceuticalsTerminatedImmunocompromisedUnited States, Mexico
-
National Institute of Allergy and Infectious Diseases...National Heart, Lung, and Blood Institute (NHLBI); Gilead Sciences; University... and other collaboratorsCompleted
-
Regeneron PharmaceuticalsCompleted
-
EyePoint Pharmaceuticals, Inc.Medical Technology Enterprise Consortium (MTEC)TerminatedCOVID-19 | Acute Respiratory Distress Syndrome (ARDS)United States
-
BioNTech SEPfizerCompletedCOVID-19 | SARS-CoV-2 InfectionUnited States, Brazil, South Africa, Germany, Canada, Israel
-
BioNTech SEPfizerCompletedCOVID-19 | Influenza, HumanUnited States
-
National Institute of Allergy and Infectious Diseases...CompletedCOVID-19United States, Japan, Mexico, Singapore, Korea, Republic of
-
National Institute of Allergy and Infectious Diseases...CompletedCOVID-19Korea, Republic of, United States, Denmark, Japan, Mexico, Singapore, Spain, United Kingdom
-
Gilead SciencesCompletedCOVID-19United States, Japan
-
Partner Therapeutics, Inc.United States Department of DefenseCompletedCovid19 | SARS-CoV InfectionUnited States, Argentina
-
Regeneron PharmaceuticalsSanofiCompletedCOVID-19United States
-
Atea Pharmaceuticals, Inc.Active, not recruitingCOVID-19 | SARS CoV 2 InfectionUnited States, Argentina, Brazil, Canada, Germany, India, Japan, Latvia, Mexico, Netherlands, Pakistan, Philippines, Romania, South Africa, Spain, Sweden, Tunisia, Turkey, United Kingdom
-
NovavaxActive, not recruitingCOVID-19Spain, United States, South Africa, Mexico, United Kingdom, Philippines, Colombia, Dominican Republic, Guatemala, Honduras
-
Eli Lilly and CompanyCompletedCOVID-19United States, Spain, India, Germany, Puerto Rico, Brazil, Korea, Republic of, Argentina, Italy, Japan, Mexico, Russian Federation, United Kingdom
-
PfizerSuspendedCOVID-19United States, United Kingdom, Japan, South Africa, Bulgaria, Puerto Rico, Mexico, Hungary
-
BioNTech SEPfizerCompletedCOVID-19 | SARS-CoV-2 Infection | Maternal ImmunizationUnited States, United Kingdom, Spain, Brazil, South Africa
-
GlaxoSmithKlineCompletedSevere Acute Respiratory SyndromeUnited States, Russian Federation, Peru, Netherlands, Spain, South Africa, United Kingdom, Argentina, Brazil, France, Canada, Mexico, Poland, Belgium, India, Japan, Chile, Colombia, Italy
-
Susanna Naggie, MDVanderbilt University Medical Center; National Center for Advancing Translational...Completed
-
PfizerTerminatedCOVID-19United States, Malaysia, Thailand, Turkey, Spain, Czechia, Poland, Bulgaria, Japan, Korea, Republic of, South Africa, Hungary, Argentina, Brazil, Colombia, Mexico, Puerto Rico, Romania, Slovakia, Ukraine
-
AstraZenecaIqvia Pty LtdCompletedCOVID-19United States, Belgium, France, Spain, United Kingdom
-
Susanna Naggie, MDVanderbilt University Medical Center; National Center for Advancing Translational...Completed
-
Susanna Naggie, MDVanderbilt University Medical Center; National Center for Advancing Translational...Completed
-
Susanna Naggie, MDVanderbilt University Medical Center; National Center for Advancing Translational...Completed
-
Susanna Naggie, MDVanderbilt University Medical Center; National Center for Advancing Translational...Completed
-
Susanna Naggie, MDVanderbilt University Medical Center; National Center for Advancing Translational...Completed
-
Vir Biotechnology, Inc.GlaxoSmithKlineCompletedCovid19United States, Canada, Spain, Austria, Brazil, Peru, United Kingdom
-
National Institute of Allergy and Infectious Diseases...CompletedSARS-CoV-2 InfectionUnited States
-
Frank C SciurbaNational Heart, Lung, and Blood Institute (NHLBI)Terminated
-
NYU Langone HealthNational Heart, Lung, and Blood Institute (NHLBI)RecruitingSARS-CoV-2 InfectionUnited States
-
PfizerCompletedCOVID-19United States, Korea, Republic of, Russian Federation, Czechia, Turkey, Malaysia, South Africa, Bulgaria, Poland, Hungary, Argentina, Brazil, Colombia, Japan, Mexico, Puerto Rico, Spain, Thailand, Ukraine, India
-
Susanna Naggie, MDVanderbilt University Medical Center; National Center for Advancing Translational...Active, not recruiting
-
Susanna Naggie, MDVanderbilt University Medical Center; National Center for Advancing Translational...Active, not recruiting
-
Massachusetts General HospitalNational Heart, Lung, and Blood Institute (NHLBI)CompletedSARS-CoV Infection | Coronavirus | Acute Respiratory InfectionUnited States
-
Saint Luke's Health SystemAstraZeneca; George Clinical Pty Ltd; Saint Luke's Hospital of Kansas CityCompletedCOVID-19United States, Brazil, Argentina, India, Canada, Mexico, United Kingdom
-
Gilead SciencesApproved for marketingSARS-CoV2 InfectionUnited States, Israel, Belgium, Spain, Australia, Denmark, Italy, Germany, France, Portugal, United Kingdom, Poland, Switzerland, Canada, Austria, Cyprus, Czechia, Estonia, Greece, Hungary, Iceland, Ireland, Lithuania, Netherlands, Romania and more
-
ShionogiNational Institute of Allergy and Infectious Diseases (NIAID)Active, not recruitingA Study to Compare S-217622 With Placebo in Non-Hospitalized Participants With COVID-19 (SCORPIO-HR)SARS-CoV-2 InfectionUnited States, India, Uganda, Poland, Philippines, Thailand, Pakistan, South Africa, Argentina, Brazil, Colombia, Ghana, Japan, Kenya, Malawi, Mexico, Turkey
-
BioNTech SEPfizerRecruitingCOVID-19 | Severe Acute Respiratory Syndrome Coronavirus 2 | SARS-CoV-2 VirusUnited States, South Africa, Brazil, Puerto Rico
-
Sean CollinsNational Heart, Lung, and Blood Institute (NHLBI); National Institutes of Health...CompletedCOVID-19 | Coronavirus Infection | SARS-CoV-2 InfectionUnited States
-
Maastricht University Medical CenterCharles University, Czech Republic; Karolinska University Hospital; Hospices... and other collaboratorsRecruitingSeptic Shock | Extracorporeal Membrane Oxygenation | COVID | SARS-CoV-2 | Cardiogenic Shock | ARDS, Human | Refractory HypoxemiaSpain, Germany, Netherlands, France, Sweden, Belgium, Austria, Portugal, Poland, United Kingdom, Italy, Lithuania, Czechia, Denmark, Greece, Hungary, Israel, Russian Federation, Switzerland
-
Kinevant Sciences GmbHRoivant Sciences, Inc.Completed